In our previous study, we found that the NAMPT-SIRT1-HSP70 pathway could control the p73 activator anticancer activity in HNSCC cells containing GOF p53 mutants [11,36]. This evidence concerns the gene SIRT1 and head and neck squamous cell carcinoma.